| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $60K | — | — |
| R&D Expense | $46K | +360.0% | -85.1% |
| SG&A Expense | $3.3M | +6.7% | +5.2% |
| Operating Income | -$29.9M | -698.8% | -765.5% |
| Net Income | -$30.8M | -746.4% | -1050.5% |
| EPS (Basic) | -$0.82 | -583.3% | -105.0% |
| EPS (Diluted) | -$0.82 | -583.3% | -105.0% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $8.8M | -13.4% | -63.1% |
| Current Assets | $10.9M | -17.6% | -55.3% |
| Total Assets | $82.9M | -26.8% | +240.1% |
| Current Liabilities | $1.1M | +1.8% | -52.5% |
| Total Liabilities | $1.1M | +1.8% | -52.5% |
| Stockholders' Equity | $81.8M |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.4M | -42.8% | — |
| Investing Cash Flow | -$99.4M | +0.6% | — |
| Financing Cash Flow | $96.6M | +0.0% | — |
| +270.4% |